The Duke-NUS Medical School in Singapore is a partnership between Duke University (USA) and the National University of Singapore. The Duke-NUS Master in International Translational Medicine (MITM) is a part-time, executive-style programme that offers a unique opportunity to learn from those directly involved in TM; engaging with world leading experts through an established partnership with the Eureka Institute.
The Duke-NUS MITM addresses a critical gap in medical researchers’ formal education: The understanding and capacity to help progress specific, targeted scientific findings (such as laboratory or clinical trials results) toward an ultimate patient-based solution.
This gap exists because of its interdisciplinary and multi-dimensional nature, which includes the need to be aware of and understand the key events and requirements necessary to progress research beyond one’s own expertise, as well as the personal and professional competencies to interact with the various stakeholders required to move a solution forward.
The Duke-NUS MITM programme strategically leverages off the strong historical partnership with the Eureka Institute for Translational Medicine. Duke-NUS, along with SingHealth – its academic medicine clinical partner – has been a strong supporter of the Eureka Institute since 2013, working in collaboration to deliver various educational outreach programmes.
It has been a goal of the Eureka Institute to support expanding the Eureka experience into advanced degree opportunities at its partner institutions, and we are delighted that the Duke-NUS MITM programme is the first of such an endeavour.
|Semester 1||Semester 2|
Translational Medicine: From Unmet Need to Cure
From need to target
From target to treatment
Entrepreneurship for TM researchers
Networking in International Translational Medicine